In response to the Federal Competition Commission’s blocking of Nestle SA’s $11.85 billion buyout of Pfizer Inc.’s infant nutrition business due to competition concerns, Nestle has reportedly agreed to divest Pfizer’s baby formula operations. The CFC originally blocked the deal last November after it found Nestle, which is based in Switzerland, would have too much of a dominant position in the market in Mexico after the acquisition. The competition authority has announced its approval of the concessions. Nestle outbid Groupe Danone SA to buy the Pfizer conglomerate last year.
Featured News
States Vow to Continue Antitrust Fight Against Live Nation Despite DOJ Settlement
Mar 9, 2026 by
CPI
White House Cybersecurity Plan Calls on Private Sector to Partner on US Operations
Mar 9, 2026 by
CPI
Big Tech Data Centers Become Wartime Targets After Drone Strikes on Amazon Sites
Mar 9, 2026 by
CPI
Anthropic Sues Pentagon to Block National Security Blacklist Over AI Restrictions
Mar 9, 2026 by
CPI
A $300 Billion Crypto Market Is Propping Up US Government Debt
Mar 9, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece